Among these missing proteins, there are also the two redundant complement inhibitors CD55 and CD59; as a consequence, PNH erythrocytes are unable to modulate complement activation on their surface, eventually accounting for the complement‐mediated intravascular hemolysis which is the hallmark of PNH.1 This evidence concerns the gene CD59 and paroxysmal nocturnal hemoglobinuria.